MGTA Annual Total Liabilities
$40.69 M
+$23.43 M+135.70%
31 December 2022
Summary:
As of January 21, 2025, MGTA annual total liabilities is $40.69 million, with the most recent change of +$23.43 million (+135.70%) on December 31, 2022. During the last 3 years, it has risen by +$20.37 million (+100.22%).MGTA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA Quarterly Total Liabilities
$4.03 M
-$1.95 M-32.56%
30 June 2023
Summary:
As of January 21, 2025, MGTA quarterly total liabilities is $4.03 million, with the most recent change of -$1.95 million (-32.56%) on June 30, 2023. Over the past year, it has dropped by -$35.41 million (-89.77%).MGTA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +135.7% | -89.8% |
| 3 y3 years | +100.2% | -76.0% |
| 5 y5 years | +882.3% | -52.0% |
MGTA Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | at high | -90.7% |
Magenta Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $4.03 M(-32.6%) |
| Mar 2023 | - | $5.98 M(-85.3%) |
| Dec 2022 | $40.69 M(+135.7%) | $40.69 M(+1.5%) |
| Sept 2022 | - | $40.10 M(+1.7%) |
| June 2022 | - | $39.44 M(-8.7%) |
| Mar 2022 | - | $43.20 M(+150.2%) |
| Dec 2021 | $17.26 M(-2.5%) | $17.26 M(+4.3%) |
| Sept 2021 | - | $16.55 M(-5.4%) |
| June 2021 | - | $17.49 M(+12.4%) |
| Mar 2021 | - | $15.56 M(-12.1%) |
| Dec 2020 | $17.71 M | $17.71 M(+10.2%) |
| Sept 2020 | - | $16.07 M(-4.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2020 | - | $16.81 M(-11.7%) |
| Mar 2020 | - | $19.04 M(-6.3%) |
| Dec 2019 | $20.32 M(+74.2%) | $20.32 M(+29.4%) |
| Sept 2019 | - | $15.70 M(-1.1%) |
| June 2019 | - | $15.88 M(+16.0%) |
| Mar 2019 | - | $13.69 M(+17.4%) |
| Dec 2018 | $11.66 M(+181.6%) | $11.66 M(-10.3%) |
| Sept 2018 | - | $13.01 M(+54.9%) |
| June 2018 | - | $8.40 M(+52.9%) |
| Mar 2018 | - | $5.49 M(+32.6%) |
| Dec 2017 | $4.14 M(+80.1%) | $4.14 M |
| Dec 2016 | $2.30 M | - |
FAQ
- What is Magenta Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Magenta Therapeutics?
- What is Magenta Therapeutics annual total liabilities year-on-year change?
- What is Magenta Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Magenta Therapeutics?
- What is Magenta Therapeutics quarterly total liabilities year-on-year change?
What is Magenta Therapeutics annual total liabilities?
The current annual total liabilities of MGTA is $40.69 M
What is the all time high annual total liabilities for Magenta Therapeutics?
Magenta Therapeutics all-time high annual total liabilities is $40.69 M
What is Magenta Therapeutics annual total liabilities year-on-year change?
Over the past year, MGTA annual total liabilities has changed by +$23.43 M (+135.70%)
What is Magenta Therapeutics quarterly total liabilities?
The current quarterly total liabilities of MGTA is $4.03 M
What is the all time high quarterly total liabilities for Magenta Therapeutics?
Magenta Therapeutics all-time high quarterly total liabilities is $43.20 M
What is Magenta Therapeutics quarterly total liabilities year-on-year change?
Over the past year, MGTA quarterly total liabilities has changed by -$35.41 M (-89.77%)